Biotech | April 20, 2026
FDA pushes forward on gene-editing therapies with new safety roadmap
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
To boost compostable packaging, resin innovation, and supply chain speed
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access
The campaign builds on the three-year partnership unveiled earlier this season
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Subscribe To Our Newsletter & Stay Updated
